Keywords: cat, acquire, canada, drug, royalty, corp, million

CAT to acquire Canada's Drug Royalty Corp for C$126 million

Article | 28 January 2002

Print This

Cambridge Antibody Technology of the UK has announced plans toacquire Canada's Drug Royalty Corp in a stock deal worth C$126 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in